Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells. (Q39675021)
Jump to navigation
Jump to search
scientific article published on 27 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells. |
scientific article published on 27 July 2010 |
Statements
Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells (English)
Yoshihide Kawasaki
Donald A Withers
Takenobu Taima
Narihiko Kakoi
Seiichi Saito